An Integrated Meta-Analysis of Secretome and Proteome Identify Potential Biomarkers of Pancreatic Ductal Adenocarcinoma

Pancreatic ductal adenocarcinoma (PDAC) is extremely aggressive, has an unfavorable prognosis, and there are no biomarkers for early detection of the disease or identification of individuals at high risk for morbidity or mortality. The cellular and molecular complexity of PDAC leads to inconsistence...

Descripción completa

Detalles Bibliográficos
Autores principales: de Oliveira, Grasieli, Paccielli Freire, Paula, Santiloni Cury, Sarah, de Moraes, Diogo, Santos Oliveira, Jakeline, Dal-Pai-Silva, Maeli, do Reis, Patrícia Pintor, Francisco Carvalho, Robson
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7140071/
https://www.ncbi.nlm.nih.gov/pubmed/32197468
http://dx.doi.org/10.3390/cancers12030716

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7140071/
https://www.ncbi.nlm.nih.gov/pubmed/32197468
http://dx.doi.org/10.3390/cancers12030716

Ejemplares similares